|
CNTLN expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.24289944792145E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.09490000025303E-07 |
| Normal-vs-Stage2 |
1.115820E-02 |
| Normal-vs-Stage3 |
4.678000E-03 |
| Normal-vs-Stage4 |
1.590770E-01 |
| Stage1-vs-Stage2 |
7.942000E-01 |
| Stage1-vs-Stage3 |
7.764800E-01 |
| Stage1-vs-Stage4 |
8.578400E-01 |
| Stage2-vs-Stage3 |
9.918800E-01 |
| Stage2-vs-Stage4 |
7.437000E-01 |
| Stage3-vs-Stage4 |
7.449600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.27950000489352E-08 |
| Normal-vs-AfricanAmerican |
2.027400E-04 |
| Normal-vs-Asian |
3.749800E-02 |
| Caucasian-vs-AfricanAmerican |
5.565400E-01 |
| Caucasian-vs-Asian |
8.076400E-01 |
| AfricanAmerican-vs-Asian |
5.855400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.96820000192477E-08 |
| Normal-vs-Female |
1.94735999999862E-05 |
| Male-vs-Female |
1.000570E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.096830E-03 |
| Normal-vs-Extreme_Weight |
9.244100E-04 |
| Normal-vs-Obese |
4.3970999999976E-05 |
| Normal-vs-Extreme_Obese |
1.038350E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.524400E-01 |
| Normal_Weight-vs-Obese |
6.074200E-02 |
| Normal_Weight-vs-Extreme_Obese |
8.979000E-01 |
| Extreme_Weight-vs-Obese |
5.371900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.935600E-01 |
| Obese-vs-Extreme_Obese |
4.198800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.333560E-02 |
| Normal-vs-Age(41-60Yrs) |
1.11650000356178E-09 |
| Normal-vs-Age(61-80Yrs) |
7.831400E-04 |
| Normal-vs-Age(81-100Yrs) |
1.017160E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.160400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.576400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.288400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.049600E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.116400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.619600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.64900040475902E-10 |
| Normal-VS-Type2 PRCC |
2.391600E-02 |
| Normal-VS-KIRP CIMP |
3.478300E-02 |
| Normal-VS-Unclassified PRCC |
4.422800E-04 |
| Type1 PRCC-VS-Type2 PRCC |
4.283000E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.695450E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.926400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.922000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.871800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.750240E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.164900E-03 |
| Normal-vs-N1 |
1.682170E-02 |
| Normal-vs-N2 |
4.619600E-01 |
| N0-vs-N1 |
1.496620E-01 |
| N0-vs-N2 |
1.287640E-01 |
| N1-vs-N2 |
3.938400E-02 |
|
|
